Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperglycemia × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 56 Neoplasms 55 Prostatic Neoplasms 38 Colorectal Neoplasms 34 Lung Neoplasms 31 Carcinoma, Non-Small-Cell Lung 22 Hematologic Neoplasms 18 Head and Neck Neoplasms 17 Neoplasm Metastasis 16 Urinary Bladder Neoplasms 14 Pancreatic Neoplasms 14 Ovarian Neoplasms 11 Multiple Myeloma 10 Motor Activity 10 Leukemia, Myeloid, Acute 10 Squamous Cell Carcinoma of Head and Neck 9 Stomach Neoplasms 8 Anxiety Disorders 8 Melanoma 7 Hematopoietic and Lymphatic System Neoplasm 7 Glioma 7 Glioblastoma 7 Colonic Neoplasms 7 Carcinoma, Renal Cell 7 COVID-19 7 Uterine Cervical Neoplasms 6 Triple Negative Breast Neoplasms 6 Recurrence 6 Mouth Neoplasms 6 Gastrointestinal Neoplasms 6

Interventions

volagidemab 2 Metformin 2 Insulin Glargine 2 Insulin 2 Fulvestrant 2 Alpelisib 2 ziprasidone 1 relacorilant 1 pembrolizumab 1 exemestane 1 dapagliflozin 1 Vildagliptin 1 Tamoxifen 1 Standard of Care 1 Olanzapine 1 Letrozole 1 Insulin Lispro 1 Injections 1 DNA, Ribosomal 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05132244 2025-09-22

PEGASUS

British Columbia Cancer Agency

Phase NA Recruiting

Gastrointestinal

Hyperglycemia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡